🔓
Sign in as a Member to unlock the full view of CRNX. · Full hedge fund list, every line-item carveout, cabinet conflicts, and politicians-trading detail.
Become a Member$24.50/mo already a Member? Sign in →
CRNX

Crinetics Pharmaceuticals, Inc.

Sector: pharmaBiotechnologyNASDAQMarket Cap: $4.01B

Crinetics is a clinical-stage biopharmaceutical company developing endocrinology treatments with minimal political/regulatory exposure relative to large-cap pharma.

Next filing → your inbox
Govt Dependence
25/100
Regulatory Density
60/100
Lobbying Intensity
5/100
Political Signal
LOW

BusinessWhat CRNX does

Crinetics Pharmaceuticals develops novel therapeutics for endocrine disorders, including somatostatin receptor ligands and other hormone-targeted treatments. The company is pre-revenue or early-stage revenue, dependent on clinical trial success and FDA approval pathways rather than established commercial operations.

12 months past · 3 months futureCRNX activity timeline

$87$60$32 OctNovDecJan '26FebMarAprMayJunJulAugSepOctNovDec ↓ PAST — recorded activity ↑ FUTURE — scheduled markups · pending votes TODAY · Sep 14 $84.95 hi $32.61 lo $84.95 CONGRESS 11 INSIDERS 0 13F FUNDS 23 BILLS 1 Gilbert Ray Cisneros (D) · Sale · 2026-07-30Gilbert Ray Cisneros (D) · Sale (Full) · 2026-07-29Gilbert Ray Cisneros (D) · Purchase · 2026-03-03 Two Sigma Investments · + $3171M · 2026-03-31Citadel Advisors · + $35M · 2025-09-30Millennium Management · + $14M · 2025-12-31Citadel Advisors · - $12M · 2025-12-31Millennium Management · - $9M · 2025-09-30Two Sigma Investments · holds $2M · 2025-12-31Two Sigma Investments · - $2M · 2025-09-30 MARKUP · Senate Health, Education, Labor, and Pensions · 2026-09-16
Congress
buy sell
Insider · Form 4
open-market buy
Hedge fund · 13F
opened + added − trimmed closed holds
Bills
past action (this ticker) upcoming markup (sector) carveout (this ticker)
244 trading days · 3 congressional trades shown · 0 insider buys · 7 13F filings · 0 past bill actions · 1 upcoming markups

Lifetime Government AwardsCRNX federal contracts

CRNX doesn't hold direct federal contracts.

Verified via USASpending.gov: $0 reported in direct prime-contract awards. Companies in this position typically sell federal services indirectly through prime contractors and integrators (e.g., Lockheed Martin, Booz Allen, Microsoft Azure) or through commercial channels that don't appear in USASpending data.

Smart Money · 13F HoldingsHedge funds holding CRNX

$3.20B
Total CRNX held by tracked 13F funds
3
Funds with CRNX positions
Two Sigma Investments $3.17B +76% 1 overlap 2026-03-31
Millennium Management $14M +39% 2025-12-31
Citadel Advisors $12M -69% 2025-12-31

Politicians Trading CRNXMembers of Congress with recent CRNX positions

2 politicians traded CRNX across 11 disclosed transactions totaling $137K (last 730 days). Greed score = composite of trade frequency, volume & recency across the politician's entire history (not just CRNX). 0-30 LOW · 30-60 MID · 60+ HIGH.

Congressional TradesWho in Congress is trading CRNX

2026-07-30 Gilbert Ray Cisneros D-California · house Sale $15,001 - $50,000
2026-07-29 Gilbert Ray Cisneros D-California · house Sale (Full) $15,001 - $50,000
2026-03-03 Gilbert Ray Cisneros D-California · house Purchase $1,001 - $15,000
2025-04-17 Gilbert Ray Cisneros D-California · house purchase $1,001 - $15,000
2025-04-17 Gilbert Ray Cisneros D-California · house Purchase $1,001 - $15,000
2025-03-19 Josh Gottheimer D-New Jersey · house Sale $1,001 - $15,000
2025-03-19 Josh Gottheimer D-New Jersey · house sale $1,001 - $15,000
2025-01-29 Gilbert Ray Cisneros D-California · house Purchase $1,001 - $15,000
2025-01-29 Gilbert Ray Cisneros D-California · house purchase $1,001 - $15,000
2024-09-25 Josh Gottheimer D-New Jersey · house purchase $1,001 - $15,000
2024-09-25 Josh Gottheimer D-New Jersey · house Purchase $1,001 - $15,000
11+ trades on file · most recent 2026-09-07

Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock

No Form 4 activity recorded in the last 180 days.

Bills to WatchLegislation flagged by our analysis

FDA drug approval timelinesInflation Reduction Act drug pricing provisionsPDUFA reauthorization

Political ProfileWhere CRNX sits in Washington

As a clinical-stage biotech with no lobbying footprint and minimal political engagement, stock movement is driven by clinical trial results and FDA decisions rather than legislative/regulatory news cycles.

Regulatory ExposureThreats & opportunities

Regulatory threats

  • FDA clinical trial delays
  • drug pricing reform
  • patent cliff exposure

Regulatory opportunities

  • Orphan drug designation
  • Breakthrough Therapy designation
  • Accelerated approval pathways
Member intelligence layer

Live signals + predictions for CRNX — for Founders

The free page above gives you the public record. Members see the real-time intelligence layer on top of it:

Become a Founder · $24.50/mo Locked rate forever · cancel anytime

Frequently AskedAbout CRNX & political exposure

Does Crinetics Pharmaceuticals, Inc. (CRNX) hold federal contracts?
No direct prime contracts reported in USASpending.gov for Crinetics Pharmaceuticals, Inc.. Companies in the semiconductor and AI hardware sectors often sell to the federal government via prime contractors and cloud resellers (Microsoft Azure, AWS, Lockheed Martin systems integration) rather than as direct primes.
Has Congress traded CRNX stock?
11 congressional trades by 2 unique members of Congress, most recently on 2026-07-30. See the Congressional Trading panel for politician-by-politician breakdown.
What is CRNX political risk profile?
Government dependence: 25/100. Lobbying intensity: 5/100. Political signal: low.
How does GovGreed track CRNX political activity?
GovGreed integrates STOCK Act congressional trade disclosures, FEC contributions, OGE executive-branch disclosures, USASpending federal contracts, Senate LDA lobbying filings, and SEC Form 4 corporate insider trades into a single queryable graph. CRNX data is updated daily from these official federal sources.